Abstract:Ischemic cardiomyopathy (ICM) is a special type of coronary heart disease or an advanced stage of the disease, which is related to the pathological mechanism of primary dilated cardiomyopathy. Ischemic cardiomyopathy mainly occurs in the long-term myocardial ischemia, resulting in diffuse myocardial fibrosis. This in turn affects the cardiac ejection function, resulting in a significant impact on myocardial systolic and diastolic function, resulting in a decrease in the cardiac ejection fraction. The pathogenesis of ICM is closely related to coronary heart disease. Mainly due to coronary atherosclerosis caused by coronary stenosis or vascular occlusion, causing vascular inflammatory lesions and thrombosis. As the disease progresses, it leads to long-term myocardial ischemia and eventually ICM. The pathological mechanism is mainly related to the mechanisms of inflammation, myocardial hypertrophy, fibrosis and vascular remodeling. Mitochondria are organelles with a double-membrane structure, so the composition of the mitochondrial outer compartment is basically similar to that of the cytoplasm. When ischemia-reperfusion induces a large influx of calcium into the cell, the concentration of calcium ions in the mitochondrial outer compartment also increases. The subsequent opening of the membrane permeability transition pore in the inner mitochondrial membrane and the resulting calcium overload induces the homeostasis of cardiomyocytes and activates the mitochondrial pathway of apoptosis. Mitochondrial Quality Control (MQC), as an important mechanism for regulating mitochondrial function in cardiomyocytes, affects the morphological structure/function and lifespan of mitochondria. In this review, we discuss the role of MQC (including mitophagy, mitochondrial dynamics, and mitochondrial biosynthesis) in the pathogenesis of ICM and provide important evidence for targeting MQC for ICM.

[Recent Progress of Mitochondrial Quality Control in Ischemic Heart Disease and Its Role in Cardio-Protection of Vagal Nerve].

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Mitophagy As a Mitochondrial Quality Control Mechanism in Myocardial Ischemic Stress: from Bench to Bedside

Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease

Mitochondrial homeostasis and redox status in cardiovascular diseases: Protective role of the vagal system

Role of mitochondrial quality surveillance in myocardial infarction: From bench to bedside

Mitochondrial Fusion and Fission in Neuronal Death Induced by Cerebral Ischemia-Reperfusion and Its Clinical Application: A Mini-Review

The Role of Mitochondrial Quality Control in Cardiac Ischemia/Reperfusion Injury

Mitochondrial quality surveillance as a therapeutic target in myocardial infarction

Mitochondrial Quality Control in Cerebral Ischemia–Reperfusion Injury

Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy

Mitochondrial quality control in acute ischemic stroke

Assessment of mitochondrial dysfunction and implications in cardiovascular disorders

Mitophagy for cardioprotection

Mitochondrial Quality Control: A Pathophysiological Mechanism and Therapeutic Target for Stroke

[Advances in Protective Effects of Vagal Nerve and Acetylcholine Against Ischemia Injury to Myocardium].

Mitochondrial transfer in the progression and treatment of cardiac disease

Mitochondrial Quality and Quantity Control: Mitophagy Is a Potential Therapeutic Target for Ischemic Stroke

Mitochondrial quality control in human health and disease

Mitochondrial Stress as a Central Player in the Pathogenesis of Hypoxia-Related Myocardial Dysfunction: New Insights